Maryland physician remotely treats opioid patients, prescribes drugs in defiance of federal law

Cara Livernois | | Health Exec | Precision Medicine

For the past two years, psychiatrist Erick Weintraub has broken a 2007 federal law by providing addiction counseling to patients from his office in Baltimore.

As the opioid epidemic continuous to gain momentum, many patients are unable to access treatment for a variety of reasons. In response, Weintraub has been counseling addiction patients and even prescribing them suboxone in defiance of a 2007 federal law requiring physicians to treat patients in person before continuing care in a telehealth setting.

“I’m not a guy in a trailer in the mountains prescribing drugs,” Weintraub told Politico. “We just felt this was a major public health crisis and we had an effective, evidence-based treatment."

Read the full story below:

Facing mounting opioid overdoses, Maryland doctor defies federal law

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.